Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 908 of 5804
-
Eye stroke treatment put to the test: can clot busters save sight?
Disease control TerminatedNon-arteritic, thromboembolic central retinal artery occlusion (CRAO) is an acute neurovascular-ophthalmological emergency which leads to severe and permanent vision loss; no evidence-based therapy does exist. Two recent meta-analyses indicate early intravenous thrombolysis to be…
Phase: PHASE3 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a standard 28-Day antibiotic course beat flexible dosing for abdominal infections?
Disease control OngoingA multicentre, open label, two-arm, parallel group, pragmatic, randomised controlled trial with internal pilot. A total of 1166 consenting adult patients with cIAI will be recruited and randomised on a 1:1 basis between 28-days antibiotics and standard care antibiotics. Patients …
Phase: PHASE3 • Sponsor: Lydia Flett • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could blocking a Tumor's blood supply shrink brain meningiomas?
Disease control Recruiting nowThe natural course for meningioma suggests that a majority will grow over time. Treatment is usually indicated in growing or symptomatic meningiomas. Surgery is usually primary treatment, but there is a significant risk of adverse effects. Stereotactic radiotherapy is most often …
Phase: NA • Sponsor: St. Olavs Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New drug BIIB115 aims to build on gene therapy for spinal muscular atrophy
Disease control OngoingIn this study, researchers will learn about a study drug called BIIB115 in healthy adult male volunteers and in participants with spinal muscular atrophy (SMA). This study will focus on children with SMA. The main objective of the study is to learn about the safety of BIIB115 an…
Phase: PHASE1 • Sponsor: Biogen • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Biobank aims to unlock genetic secrets of rare diseases
Knowledge-focused Recruiting nowNext generation sequencing (NGS) allows some better diagnostic results, particularly, in the rare diseases field. At a twenty five percent rate, those exams highlight some variants which are not yet described in human pathology. The relationship between a variant found inside a c…
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Smartwatch could spot silent heart rhythm problem after surgery
Diagnosis Recruiting nowThe incidence of postoperative atrial fibrillation (POAF) after on-pump cardiac surgery remains high, at around 30%. POAF increases the risk of cardiac decompensation, stroke, acute myocardial infarction, and death, resulting in increased morbidity and mortality, hospital length …
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Could a Telomerase-Based peptide slow Alzheimer's? new trial results are in
Disease control CompletedThe current study is being conducted by the Sponsor to evaluate the efficacy and safety of GV1001 (0.56 mg and 1.12 mg) administered subcutaneously as a treatment for mild to moderate Alzheimer's disease (AD). Studies using in vivo and in vitro AD models have shown that GV1001 in…
Phase: PHASE2 • Sponsor: GemVax & Kael • Aim: Disease control
Last updated Jun 26, 2026 13:26 UTC
-
Which biopsy method best spots early esophageal cancer?
Diagnosis Recruiting nowThe purpose of this research study is to learn about the best approach to sample patients with known or suspected Barrett's esophagus (BE) by comparing the standard Seattle biopsy protocol to sampling using wide area transepithelial sampling (WATS3D). Barrett's esophagus is a co…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Web tool aims to spot hidden cancer in large colon polyps without special equipment
Knowledge-focused Recruiting nowColorectal cancer can be effectively prevented by removal of pre-malignant polyps during colonoscopy. Large (\>=20mm) non-pedunculated colorectal polyps (LNPCPs) require careful assessment before treatment. If submucosal invasive cancer (SMI) is present, it determines whether end…
Sponsor: University Hospital, Ghent • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
One-Shot knee injection could ease arthritis pain
Symptom relief CompletedA double-blind, randomized, placebo-controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of single injection of RTX-GRT7039 versus placebo in patients who have pain associated with osteoarthritis of the knee despite standard of care.
Phase: PHASE3 • Sponsor: Grünenthal GmbH • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Morning vs. afternoon chemo: which is better for lung cancer?
Disease control CompletedThis study aims to explore time-of-day of administration of immunochemotherapy on the efficacy for treatment naive advanced non-small cell lung cancer.
Phase: PHASE3 • Sponsor: Hunan Province Tumor Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Spinal cord repair: could cell injections restore function in transverse myelitis?
Disease control Recruiting nowThis study is a non-randomized, open-label, partially blinded, sequential cohort, dose-escalation study designed to obtain preliminary data on the safety, tolerability, and early activity of Q-Cells® transplantation in subjects with Transverse Myelitis. For each of the dose level…
Phase: PHASE1, PHASE2 • Sponsor: Q Therapeutics, Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
100,000 poop samples could unlock secrets of gut health and disease
Knowledge-focused Recruiting now" The French Gut " is a national contribution aiming to collect 100,000 faecal samples and associated nutritional and clinical data by 2027. Le French Gut is initiated by MetaGenoPolis-INRAE, supported by INRAE with Prof. R. Benamouzig, (AP-HP) as principal investigator of the pr…
Sponsor: Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Nose swab could stop staph infections after broken leg surgery
Prevention OngoingThe purpose of this study is to see whether applying povidone iodine (PVI) to the noses of patients undergoing lower extremity (leg, ankle, or foot) orthopedic fixation procedures of high-energy lower extremity fractures (HELEF) will decrease the patients' risk of surgical site i…
Phase: PHASE4 • Sponsor: Loreen Herwaldt • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
Mpox drug trial halted: did tecovirimat help?
Disease control TerminatedThe purpose of this study was to see if tecovirimat is safe and successful at treating mpox. The main questions were whether tecovirimat reduced time to lesion resolution and pain compared to placebo (no treatment).
Phase: PHASE3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New targeted pill shows promise for rare lung cancer mutation
Disease control CompletedThe Drugs Controller General of India (DCGI) has granted approval for Rahika® (Capmatinib) film-coated tablet 150 and 200 mg for the treatment of adult patients with advanced/metastatic NSCLC whose tumors have a mutation that leads to MET exon 14 skipping mutation with condition …
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New catheter device aims to fix leaky heart valves without open surgery
Disease control Recruiting nowStudy to evaluate the safety and performance of the INNOVALVE system
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New migraine combo drug shows promise for Tough-to-Treat patients
Symptom relief CompletedThis is a multicenter, open-label trial to evaluate the efficacy and safety of AXS-07 in subjects with migraine attacks and prior inadequate response to oral CGRP inhibitors.
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Veterans study to reveal best prostate cancer pill
Disease control Recruiting nowThe investigators have used national VHA data to demonstrate real-world efficacy of abiraterone and enzalutamide in Veterans with mCRPC. In the real-world that is the VHA, the investigators have successfully estimated g values that accurately predict OS and the use of this metric…
Phase: PHASE2 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could early radiation prevent spine fractures in cancer patients?
Disease control Recruiting nowEarly palliative care has been shown to improve the quality of life and even survival for patients with metastatic cancer. More and more supportive oncology teams in cancer centers now advocate for early integration of radiation therapy (RT) in a patient's palliative management c…
Phase: PHASE1, PHASE2 • Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC